Developer docs
API playgroundTry for free, no card

Search company profiles

Conagen

Full company profile

uuid0000rws

Namestring
Conagen
Legal namestring
Conagen Incorporated
Websiteurl
conagen.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Conagen is a privately held synthetic biology and biological manufacturing company founded in 2010 and headquartered in Bedford, Massachusetts. The company engineers microbial strains and runs fermentation-based processes to produce nature-identical ingredients — including sweeteners (BESTEVIA stevia), flavors and fragrances, amino acids, lipids, flavonoids, terpenoids, carotenoids, polysaccharides, human milk oligosaccharides, lactoferrin, postbiotic butyrate (FBA), and debondable hot melt adhesives — for enterprise customers in food and beverage, flavor and fragrance, nutraceuticals, cosmetics, specialty chemicals, and pharmaceuticals.

The technical platform rests on proprietary metabolic pathway engineering and strain development across more than 15 platform organisms, supported by custom laboratory robotics that screens hundreds of thousands of samples daily. Fermentation process development spans microliters in the lab to metric tons at commercial scale, with documented scale-up to 250,000 liters on the Conamax microbial antibody platform, which targets biopharmaceutical manufacturing with productivities above 1 gram per liter per day. Conagen claims 40+ products at commercial scale through its integrated stack of strain engineering, process development, scale-up manufacturing, and analytical chemistry capabilities.

Commercially, Conagen operates a B2B enterprise model with three revenue streams: ingredient supply (one-time product sales of nature-identical compounds), contract manufacturing services (strain development and fermentation scale-up), and technology licensing (e.g., BESTEVIA and Conamax). Pricing is custom and quote-based. Distribution is primarily direct to blue-chip enterprise customers, with selective channel partnerships such as Sweegen, which holds exclusive distribution rights for the BESTEVIA stevia line in food, confection, and beverage. Manufacturing is delivered through exclusive affiliate-company partnerships that provide vertical integration from research through world-scale production. The company is founder-led (CEO and co-founder Oliver Yu) and has raised approximately $30.2M in disclosed funding, headlined by a 2020 strategic investment from Sumitomo Chemical.

Short descriptiontext

Conagen is a Bedford, Massachusetts-based synthetic biology company that engineers microbial strains and runs fermentation processes to produce nature-identical ingredients — including stevia sweeteners, flavors, amino acids, HMOs, and antibodies — for enterprise customers in food, nutrition, pharma, and specialty chemicals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBedford, United States
HQ citystring
Bedford
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
synthetic biology, fermentation manufacturing, bio-engineered ingredients, monoclonal antibody production, natural flavor production
Industry4 codes
PRIMARYCRADAOAI
Cultures, Probiotics & Fermentation Ingredients (Starter Cultures, Yeast, Adjuncts)
SECONDARYHLAAAJAI
Bioprocess Consumables & Reagents (resins, membranes, media components, buffers)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYAFAJAMAK
Stabilizer & Texturizer Systems/Blends (Custom Hydrocolloid Blends, Application-Specific Systems)
Agriculture & Food Production/Food Ingredients & Additives/Texturizers (Thickeners & Stabilizers)
SECONDARYHLAGAHAG
Impurity / Reference Standard Synthesis & Characterization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
NAICS code4 codes
  • Medicinal and Botanical Manufacturing325411
  • Nonchocolate Confectionery Manufacturing311340
  • Chemical Manufacturing325
  • Food Manufacturing311
SIC code3 codes
  • Medicinal Chemicals & Botanical Products2833
  • Sugar & Confectionery Products2060
  • Miscellaneous Chemical Products2890
Product category
Bio-manufactured Specialty Ingredients
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1B2B Product Sales
TypeOne Time License
Description

Conagen manufactures and sells natural ingredients (sweeteners, flavors, fragrances, nutraceuticals, lipids, amino acids, etc.) to food and beverage, cosmetics, pharmaceutical, and specialty chemical companies. Products are sold under partner brands or as ingredients.

conagen.com
2Manufacturing Services
TypeProfessional Services
Description

Provides fermentation scale-up and manufacturing services for partners, taking products from lab scale through commercial production. Vertically integrated manufacturing capabilities are offered as a service.

conagen.com
3Technology Licensing
TypeLicensing Royalties
Description

Licenses proprietary technologies and processes such as BESTEVIA stevia production methods and Conamax antibody production platform to partners for use in their products.

conagen.com
4Ingredient Supply
TypeOne Time License
Description

Supplies nature-identical ingredients to manufacturers who use them in consumer products. Products include vanilla flavor, gamma-decalactone, L-ergothioneine, human milk oligosaccharides, and other specialty compounds.

conagen.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1BESTEVIA
Description

A line of commercial stevia products created through enzymatic bio-engineering, offering superior taste profiles and zero calories for food, confection, and beverage industries. Developed in partnership with Sweegen.

conagen.com
+1 more record
Core offering1 text field

Conagen is a synthetic biology company that develops and manufactures nature-identical ingredients through proprietary strain development, fermentation, and enzymatic bioconversion processes. They produce sweeteners, flavors, fragrances, amino acids, lipids, flavonoids, HMOs, monoclonal antibodies, debondable adhesives, and specialty chemicals for food, beverage, pharmaceutical, cosmetics, and industrial markets. The company is vertically integrated from research and development through commercial-scale manufacturing, operating as a contract development and manufacturing organization (CDMO) alongside its own branded ingredient portfolio.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 40+ products at commercial scale
+3 more records
Product overview1 text field

Conagen is a synthetic biology and biological manufacturing company that develops and produces natural ingredients through proprietary strain development, fermentation, and enzymatic bioconversion. The company offers a portfolio of bio-manufactured products including BESTEVIA® stevia sweeteners, the Conamax™ microbial antibody production platform, amino acids (L-ergothioneine), lipids (gamma-decalactone), flavonoids and phenolics (dihydroquercetin), terpenoids and carotenoids, polysaccharides and oligosaccharides, human milk oligosaccharides (HMOs), postbiotic FBA (butyrate), human lactoferrin, and debondable hot melt adhesives. Conagen also provides contract manufacturing services including strain development, fermentation process development, commercial-scale production, analytical chemistry, and laboratory automation. The company operates as a vertically integrated organization from bench to world-scale production, serving the food and beverage, flavor and fragrance, nutrition, pharmaceutical, cosmetics, and specialty chemical industries.

Product and service15 records
1BESTEVIA® Stevia Sweeteners
CategoryNatural Sweeteners
Description

A line of natural zero-calorie stevia sweeteners produced through fermentation, offering superior taste profiles with no bitter aftertaste. Sold to food, confection, and beverage manufacturers as natural food sweeteners.

2Conamax™ (CMAX™) Monoclonal Antibody Platform
CategoryBiopharmaceutical Manufacturing Platform
Description

A proprietary microbial antibody production platform that enables rapid, high-quality therapeutic antibody manufacturing with human-like glycosylation at reduced costs compared to traditional mammalian expression systems. Serves pharmaceutical companies seeking affordable biologics manufacturing.

3Amino Acids & Derived Compounds
CategoryAmino Acid Ingredients
Description

Fermented amino acids including L-ergothioneine produced through proprietary strain development. Used in nutritional products, infant formula, and pharmaceutical applications for antioxidant properties and healthy aging benefits.

4Lipids & Flavor Compounds
CategoryLipid Ingredients
Description

Bioengineered lipids including gamma-decalactone and flavor compounds (strawberry, peach, coconut, capsaicin) produced through enzymatic bioconversion and fermentation for infant formulas, fortified foods, nutraceuticals, and fragrances.

5Flavonoids and Phenolics
CategoryPlant-Based Bioactive Ingredients
Description

Biosynthesized flavonoids and phenolic compounds including dihydroquercetin (DHQ), pyrroloquinoline quinone, catechins, and curcuminoids. Used as antioxidants, preservatives, and functional ingredients in cosmetics, nutraceuticals, and functional beverages.

6Terpenoids and Carotenoids
CategoryTerpenoid and Carotenoid Ingredients
Description

Diverse terpenoid and carotenoid compounds produced through high-yielding fermentation platforms, including natural pigments, functional ingredients, nutritional supplements, food flavorings, fragrances, and colorants.

7Polysaccharides & Oligosaccharides
CategoryCarbohydrate Ingredients
Description

Carbohydrate synthesis products including pharmaceutical compounds (heparin, chondroitin), stevia glycosides, and food ingredients. Used as dietary fibers, thickening agents, emulsifiers, stabilizers, prebiotics, and fat replacers.

8Human Milk Oligosaccharides (HMOs)
CategoryInfant Nutrition Ingredients
Description

Scalable, non-GMO HMOs including 2'-fucosyllactose (2'-FL) produced through enzymatic processes for infant nutrition applications, enabling brands to fortify digestive and immune wellness.

9FBA (Postbiotic Butyrate)
CategoryPostbiotic Ingredients
Description

An odorless butyrate compound developed for digestive and gut health applications in infants and adults. The first odorless source of butyrate, available for licensing for dietary supplements and nutritional products.

10Human Lactoferrin
CategoryInfant Nutrition Ingredients
Description

Fermentation-produced human lactoferrin for infant nutrition and iron deficiency applications, offering high quality, sustainable, rapid, and cost-effective production with simplified downstream purification.

11Debondable Hot Melt Adhesives
CategorySpecialty Industrial Adhesives
Description

Sustainable, high-performance structural adhesives that are strong yet can be debonded before final finishing operations. A patented solution that outperforms petroleum-based products with sustainable advantages.

12Natural Flavors & Fragrances
CategoryNatural Flavors and Fragrances
Description

Natural flavors and fragrances produced through enzymatic conversion and microbial culture, including mint, fruit flavors (peach, strawberry, orange, vanilla, coconut), floral scents (rose, violet), and natural colorants.

13Fermentation Process Development Services
CategoryContract Development Services
Description

Biological process development services for scaling fermentation from microliters to metric tons, with processes developed for 40+ different products at commercial scale. Provided to enterprise partners on a contract basis.

14Commercial-Scale Microbial Fermentation Manufacturing
CategoryContract Manufacturing Services
Description

World-scale contract manufacturing capabilities for microbial fermentation products from pilot to commercial production, with facilities capable of scaling up to 250,000 liters.

15Strain Development & Metabolic Pathway Engineering Services
CategoryContract R&D Services
Description

Development of novel microbial strains using 14+ different platform organisms and proprietary tools for industrial fermentation of sustainable bio-products. Provided to enterprise partners on a contract basis.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Sweegen
Strategic tierCoreTypeGTM or Marketing Partner
Description

Conagen partnered with Sweegen to create the Signature BESTEVIA line of commercial Stevia products. Conagen develops and manufactures the products using their proprietary enzymatic bio-engineering process, while Sweegen distributes and sells the products in the food, confection, and beverage industries. This is a core commercial partnership bringing Conagen's natural sweeteners to market under Sweegen's brand.

conagen.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Amyris
TypeDirect peer
Description

Amyris is a synthetic biology company that engineered yeast strains to produce fermentation-derived ingredients including flavors, fragrances, and sweeteners. It is the closest historical peer to Conagen in applying strain engineering to ingredient commercialization at scale, though Amyris's restructuring illustrates both the opportunity and execution risk in this model.

TypeDirect peer
Description

Ginkgo Bioworks operates a synthetic biology platform that programs microbial strains for customers across food, pharma, and industrial markets. Both companies use proprietary strain engineering to produce nature-identical molecules through fermentation, though Ginkgo's cell engineering platform model and Conagen's vertically integrated manufacturing model differ in go-to-market.

TypeDirect peer
Description

Codexis engineers enzymes and microbial strains for pharmaceutical and food ingredient manufacturing. Both companies serve overlapping end markets (pharma APIs, food ingredients) using protein engineering and fermentation, with comparable emphasis on biocatalysis and process scale-up.

TypeBroad incumbent
Description

Novonesis is a global leader in industrial enzymes and microbial fermentation, serving food, beverage, and specialty chemical markets. While far larger and more diversified than Conagen, the company competes in the same enzyme and fermentation ingredient categories and operates at world-scale.

TypeBroad incumbent
Description

dsm-firmenich is a major nutrition, health, and specialty ingredients company with deep positions in flavors, fragrances, and functional food ingredients. The company's broad ingredient portfolio and global manufacturing footprint overlap with several of Conagen's target markets.

TypeBroad incumbent
Description

IFF is a major global supplier of flavors, fragrances, and food ingredients, including products produced via fermentation and biotechnology. Conagen's flavors and fragrances business targets customers who currently purchase from IFF, making it a key incumbent competitor.

TypeBroad incumbent
Description

Cargill is one of the world's largest food ingredient suppliers, with significant investments in fermentation-based sweeteners, flavors, and specialty ingredients. Conagen competes for ingredient supply contracts with food and beverage customers who currently buy from Cargill.

TypeBroad incumbent
Description

Ajinomoto is a global leader in fermentation-based amino acid production and a major food and nutraceutical ingredient supplier. Conagen's amino acids product line (including L-ergothioneine) directly competes with Ajinomoto's offerings in nutritional and pharmaceutical markets.

TypeBroad incumbent
Description

Chr. Hansen specializes in fermentation-based ingredients including cultures, enzymes, and natural colors for food, beverage, and supplement markets. Its fermentation platform and microbial strain capabilities are directly comparable to Conagen's core technology.

10Sweegen
TypeOthers
Description

Sweegen is a sweetener ingredient company that commercializes stevia and other natural sweeteners for food and beverage customers. Sweegen is primarily a customer/distribution partner of Conagen for the BESTEVIA product line rather than a direct competitor, but it illustrates the type of ingredient company in Conagen's commercial orbit.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Conagen

Bio-manufactured Specialty Ingredientsconagen.com

Conagen is a Bedford, Massachusetts-based synthetic biology company that engineers microbial strains and runs fermentation processes to produce nature-identical ingredients — including stevia sweeteners, flavors, amino acids, HMOs, and antibodies — for enterprise customers in food, nutrition, pharma, and specialty chemicals.

What Conagen does

Conagen is a privately held synthetic biology and biological manufacturing company founded in 2010 and headquartered in Bedford, Massachusetts. The company engineers microbial strains and runs fermentation-based processes to produce nature-identical ingredients — including sweeteners (BESTEVIA stevia), flavors and fragrances, amino acids, lipids, flavonoids, terpenoids, carotenoids, polysaccharides, human milk oligosaccharides, lactoferrin, postbiotic butyrate (FBA), and debondable hot melt adhesives — for enterprise customers in food and beverage, flavor and fragrance, nutraceuticals, cosmetics, specialty chemicals, and pharmaceuticals.

The technical platform rests on proprietary metabolic pathway engineering and strain development across more than 15 platform organisms, supported by custom laboratory robotics that screens hundreds of thousands of samples daily. Fermentation process development spans microliters in the lab to metric tons at commercial scale, with documented scale-up to 250,000 liters on the Conamax microbial antibody platform, which targets biopharmaceutical manufacturing with productivities above 1 gram per liter per day. Conagen claims 40+ products at commercial scale through its integrated stack of strain engineering, process development, scale-up manufacturing, and analytical chemistry capabilities.

Commercially, Conagen operates a B2B enterprise model with three revenue streams: ingredient supply (one-time product sales of nature-identical compounds), contract manufacturing services (strain development and fermentation scale-up), and technology licensing (e.g., BESTEVIA and Conamax). Pricing is custom and quote-based. Distribution is primarily direct to blue-chip enterprise customers, with selective channel partnerships such as Sweegen, which holds exclusive distribution rights for the BESTEVIA stevia line in food, confection, and beverage. Manufacturing is delivered through exclusive affiliate-company partnerships that provide vertical integration from research through world-scale production. The company is founder-led (CEO and co-founder Oliver Yu) and has raised approximately $30.2M in disclosed funding, headlined by a 2020 strategic investment from Sumitomo Chemical.

Conagen firmographics

Firmographics
Name
Conagen
Legal name
Conagen Incorporated
Website
https://conagen.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Short description
Conagen is a Bedford, Massachusetts-based synthetic biology company that engineers microbial strains and runs fermentation processes to produce nature-identical ingredients — including stevia sweeteners, flavors, amino acids, HMOs, and antibodies — for enterprise customers in food, nutrition, pharma, and specialty chemicals.
Ownership category
akta.pro rank

Conagen industry classification

Industry
Product category
Bio-manufactured Specialty Ingredients
NAICS
Medicinal and Botanical Manufacturing (325411), Nonchocolate Confectionery Manufacturing (311340), Chemical Manufacturing (325), Food Manufacturing (311)
SIC
Medicinal Chemicals & Botanical Products (2833), Sugar & Confectionery Products (2060), Miscellaneous Chemical Products (2890)
akta.pro industry
PRIMARYCRADAOAI
Cultures, Probiotics & Fermentation Ingredients (Starter Cultures, Yeast, Adjuncts)
SECONDARYHLAAAJAI
Bioprocess Consumables & Reagents (resins, membranes, media components, buffers)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYAFAJAMAK
Stabilizer & Texturizer Systems/Blends (Custom Hydrocolloid Blends, Application-Specific Systems)
Agriculture & Food Production/Food Ingredients & Additives/Texturizers (Thickeners & Stabilizers)
SECONDARYHLAGAHAG
Impurity / Reference Standard Synthesis & Characterization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

  • Synthetic biology
  • Fermentation manufacturing
  • Bio-engineered ingredients
  • Monoclonal antibody production
  • Natural flavor production

Where Conagen is headquartered

Location

Headquarters

HQ city
Bedford
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Conagen business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. B2B Product Sales: Conagen manufactures and sells natural ingredients (sweeteners, flavors, fragrances, nutraceuticals, lipids, amino acids, etc.) to food and beverage, cosmetics, pharmaceutical, and specialty chemical companies. Products are sold under partner brands or as ingredients.
  2. Manufacturing Services: Provides fermentation scale-up and manufacturing services for partners, taking products from lab scale through commercial production. Vertically integrated manufacturing capabilities are offered as a service.
  3. Technology Licensing: Licenses proprietary technologies and processes such as BESTEVIA stevia production methods and Conamax antibody production platform to partners for use in their products.
  4. Ingredient Supply: Supplies nature-identical ingredients to manufacturers who use them in consumer products. Products include vanilla flavor, gamma-decalactone, L-ergothioneine, human milk oligosaccharides, and other specialty compounds.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Conagen product offering

Product offering

Core offering

Conagen is a synthetic biology company that develops and manufactures nature-identical ingredients through proprietary strain development, fermentation, and enzymatic bioconversion processes. They produce sweeteners, flavors, fragrances, amino acids, lipids, flavonoids, HMOs, monoclonal antibodies, debondable adhesives, and specialty chemicals for food, beverage, pharmaceutical, cosmetics, and industrial markets. The company is vertically integrated from research and development through commercial-scale manufacturing, operating as a contract development and manufacturing organization (CDMO) alongside its own branded ingredient portfolio.

Product overview

Conagen is a synthetic biology and biological manufacturing company that develops and produces natural ingredients through proprietary strain development, fermentation, and enzymatic bioconversion. The company offers a portfolio of bio-manufactured products including BESTEVIA® stevia sweeteners, the Conamax™ microbial antibody production platform, amino acids (L-ergothioneine), lipids (gamma-decalactone), flavonoids and phenolics (dihydroquercetin), terpenoids and carotenoids, polysaccharides and oligosaccharides, human milk oligosaccharides (HMOs), postbiotic FBA (butyrate), human lactoferrin, and debondable hot melt adhesives. Conagen also provides contract manufacturing services including strain development, fermentation process development, commercial-scale production, analytical chemistry, and laboratory automation. The company operates as a vertically integrated organization from bench to world-scale production, serving the food and beverage, flavor and fragrance, nutrition, pharmaceutical, cosmetics, and specialty chemical industries.

Differentiator

Problem solved

Functional benefit

Brands

  • BESTEVIA: A line of commercial stevia products created through enzymatic bio-engineering, offering superior taste profiles and zero calories for food, confection, and beverage industries. Developed in partnership with Sweegen.
  • Conamax (CMAX)

Products and services

  • BESTEVIA® Stevia Sweeteners A line of natural zero-calorie stevia sweeteners produced through fermentation, offering superior taste profiles with no bitter aftertaste. Sold to food, confection, and beverage manufacturers as natural food sweeteners.
  • Conamax™ (CMAX™) Monoclonal Antibody Platform A proprietary microbial antibody production platform that enables rapid, high-quality therapeutic antibody manufacturing with human-like glycosylation at reduced costs compared to traditional mammalian expression systems. Serves pharmaceutical companies seeking affordable biologics manufacturing.
  • Amino Acids & Derived Compounds Fermented amino acids including L-ergothioneine produced through proprietary strain development. Used in nutritional products, infant formula, and pharmaceutical applications for antioxidant properties and healthy aging benefits.
  • Lipids & Flavor Compounds Bioengineered lipids including gamma-decalactone and flavor compounds (strawberry, peach, coconut, capsaicin) produced through enzymatic bioconversion and fermentation for infant formulas, fortified foods, nutraceuticals, and fragrances.
  • Flavonoids and Phenolics Biosynthesized flavonoids and phenolic compounds including dihydroquercetin (DHQ), pyrroloquinoline quinone, catechins, and curcuminoids. Used as antioxidants, preservatives, and functional ingredients in cosmetics, nutraceuticals, and functional beverages.
  • Terpenoids and Carotenoids Diverse terpenoid and carotenoid compounds produced through high-yielding fermentation platforms, including natural pigments, functional ingredients, nutritional supplements, food flavorings, fragrances, and colorants.
  • Polysaccharides & Oligosaccharides Carbohydrate synthesis products including pharmaceutical compounds (heparin, chondroitin), stevia glycosides, and food ingredients. Used as dietary fibers, thickening agents, emulsifiers, stabilizers, prebiotics, and fat replacers.
  • Human Milk Oligosaccharides (HMOs) Scalable, non-GMO HMOs including 2'-fucosyllactose (2'-FL) produced through enzymatic processes for infant nutrition applications, enabling brands to fortify digestive and immune wellness.
  • FBA (Postbiotic Butyrate) An odorless butyrate compound developed for digestive and gut health applications in infants and adults. The first odorless source of butyrate, available for licensing for dietary supplements and nutritional products.
  • Human Lactoferrin Fermentation-produced human lactoferrin for infant nutrition and iron deficiency applications, offering high quality, sustainable, rapid, and cost-effective production with simplified downstream purification.
  • Debondable Hot Melt Adhesives Sustainable, high-performance structural adhesives that are strong yet can be debonded before final finishing operations. A patented solution that outperforms petroleum-based products with sustainable advantages.
  • Natural Flavors & Fragrances Natural flavors and fragrances produced through enzymatic conversion and microbial culture, including mint, fruit flavors (peach, strawberry, orange, vanilla, coconut), floral scents (rose, violet), and natural colorants.
  • Fermentation Process Development Services Biological process development services for scaling fermentation from microliters to metric tons, with processes developed for 40+ different products at commercial scale. Provided to enterprise partners on a contract basis.
  • Commercial-Scale Microbial Fermentation Manufacturing World-scale contract manufacturing capabilities for microbial fermentation products from pilot to commercial production, with facilities capable of scaling up to 250,000 liters.
  • Strain Development & Metabolic Pathway Engineering Services Development of novel microbial strains using 14+ different platform organisms and proprietary tools for industrial fermentation of sustainable bio-products. Provided to enterprise partners on a contract basis.

Quantifiable outcome

  • 40+ products at commercial scale
  • +3 more outcomes

Companies that use Conagen

Customer profile

Named customers1 record

Segments7 records

Ideal customer profiles6 records

Conagen technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Conagen partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • SweegencoreGTM or Marketing PartnerConagen partnered with Sweegen to create the Signature BESTEVIA line of commercial Stevia products. Conagen develops and manufactures the products using their proprietary enzymatic bio-engineering process, while Sweegen distributes and sells the products in the food, confection, and beverage industries. This is a core commercial partnership bringing Conagen's natural sweeteners to market under Sweegen's brand.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Conagen competitors and assessment

Company assessment

Direct peers

  • Amyris: Amyris is a synthetic biology company that engineered yeast strains to produce fermentation-derived ingredients including flavors, fragrances, and sweeteners. It is the closest historical peer to Conagen in applying strain engineering to ingredient commercialization at scale, though Amyris's restructuring illustrates both the opportunity and execution risk in this model.
  • Ginkgo Bioworks: Ginkgo Bioworks operates a synthetic biology platform that programs microbial strains for customers across food, pharma, and industrial markets. Both companies use proprietary strain engineering to produce nature-identical molecules through fermentation, though Ginkgo's cell engineering platform model and Conagen's vertically integrated manufacturing model differ in go-to-market.
  • Codexis: Codexis engineers enzymes and microbial strains for pharmaceutical and food ingredient manufacturing. Both companies serve overlapping end markets (pharma APIs, food ingredients) using protein engineering and fermentation, with comparable emphasis on biocatalysis and process scale-up.

Broad incumbents

  • Novonesis (formerly Novozymes): Novonesis is a global leader in industrial enzymes and microbial fermentation, serving food, beverage, and specialty chemical markets. While far larger and more diversified than Conagen, the company competes in the same enzyme and fermentation ingredient categories and operates at world-scale.
  • dsm-firmenich: dsm-firmenich is a major nutrition, health, and specialty ingredients company with deep positions in flavors, fragrances, and functional food ingredients. The company's broad ingredient portfolio and global manufacturing footprint overlap with several of Conagen's target markets.
  • International Flavors & Fragrances (IFF): IFF is a major global supplier of flavors, fragrances, and food ingredients, including products produced via fermentation and biotechnology. Conagen's flavors and fragrances business targets customers who currently purchase from IFF, making it a key incumbent competitor.
  • Cargill: Cargill is one of the world's largest food ingredient suppliers, with significant investments in fermentation-based sweeteners, flavors, and specialty ingredients. Conagen competes for ingredient supply contracts with food and beverage customers who currently buy from Cargill.
  • Ajinomoto: Ajinomoto is a global leader in fermentation-based amino acid production and a major food and nutraceutical ingredient supplier. Conagen's amino acids product line (including L-ergothioneine) directly competes with Ajinomoto's offerings in nutritional and pharmaceutical markets.
  • Chr. Hansen (now part of Novonesis): Chr. Hansen specializes in fermentation-based ingredients including cultures, enzymes, and natural colors for food, beverage, and supplement markets. Its fermentation platform and microbial strain capabilities are directly comparable to Conagen's core technology.

Others

  • Sweegen: Sweegen is a sweetener ingredient company that commercializes stevia and other natural sweeteners for food and beverage customers. Sweegen is primarily a customer/distribution partner of Conagen for the BESTEVIA product line rather than a direct competitor, but it illustrates the type of ingredient company in Conagen's commercial orbit.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Conagen social profiles

Digital presence

Conagen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Conagen leadership team

Management profile

Number of profiles

Profiles1 record

Conagen funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Conagen M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Conagen

What does Conagen do?

Conagen is a synthetic biology company that develops and manufactures nature-identical ingredients through proprietary strain development, fermentation, and enzymatic bioconversion processes. They produce sweeteners, flavors, fragrances, amino acids, lipids, flavonoids, HMOs, monoclonal antibodies, debondable adhesives, and specialty chemicals for food, beverage, pharmaceutical, cosmetics, and industrial markets. The company is vertically integrated from research and development through commercial-scale manufacturing, operating as a contract development and manufacturing organization (CDMO) alongside its own branded ingredient portfolio.

Is Conagen a public or private company?

Conagen is a private company. It is classified as venture growth investor backed and is currently operating.

When was Conagen founded?

Conagen was founded in 2010. It employs 11 to 50 people.

Where is Conagen based?

Conagen is headquartered in Bedford, United States, in the North America region.

How does Conagen make money?

Four revenue lines are on record. B2B Product Sales are the primary driver. The others are manufacturing Services, technology Licensing and ingredient Supply.

Who are Conagen's main competitors?

Direct peers on record are Amyris, Ginkgo Bioworks and Codexis. Broad incumbents are Novonesis (formerly Novozymes), dsm-firmenich, International Flavors & Fragrances (IFF), Cargill, Ajinomoto and Chr. Hansen (now part of Novonesis). Sweegen is listed as an others.

Does Conagen have an API?

No public API is recorded for Conagen.

What industry is Conagen in?

Conagen's product category is Bio-manufactured Specialty Ingredients. Its primary akta.pro industry code is CRADAOAI, Cultures, Probiotics & Fermentation Ingredients (Starter Cultures, Yeast, Adjuncts), with a secondary code of HLAAAJAI, Bioprocess Consumables & Reagents (resins, membranes, media components, buffers). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Nutritional OutlookConagen scales up production of two new high-intensity natural sweeteners derived from thaumatin proteinConagen has successfully scaled up production of two new natural, high-intensity sweeteners (thaumatin I and thaumatin II) derived from the tropical plant Thaumatococcus daniellii, in partnership with Sweegen. The sweeteners are 100,000 times sweeter than sugar on a molar basis and 3,000 times sweeter on a weight basis, produced using Conagen's proprietary precision fermentation process. Sweegen will add these zero-sugar sweeteners to its portfolio alongside existing options like brazzein and stevia, with regulatory approval already secured in the European Union, Israel, and Japan.WeforumHow synthetic biology could improve supply chain resilienceGlobal supply chains are struggling due to multiple compounding crises including war, climate disruption, energy instability, and food shortages, and synthetic biology is emerging as a potential solution to develop more efficient and cost-effective materials and energy sources. Companies such as Ginkgo Bioworks, Twist Bioscience, Conagen, Pivot Bio, AmSilk, Colorifix, Biomason, Solar Foods, Air Protein, Orbital Farms, and Solugen are developing applications ranging from sustainable proteins and fertilizers to bio-fabricated textiles and biological construction materials. The article suggests that with sufficient investment, innovation, and scaling, synthetic biology's circular manufacturing approach could be deployed anywhere to strengthen supply chain resilience against future disruptions.SynBioBetaSynthetic Biology’s Path to Sustainable Food SystemsThe article explores how synthetic biology is driving progress in cellular agriculture, highlighting that cultivated meat costs have dropped exponentially since the first $300,000 burger was produced over a decade ago, though price parity with conventional meat remains elusive. Industry leaders identify scaling production and securing capital investment as the biggest remaining challenges, with some advocating for government support to bridge funding gaps while navigating regulatory frameworks. Companies like Blue Nalu, Hoxton Farms, Aleph Farms, De Novo Foodlabs, and Conagen are working on various solutions, from cultivated seafood and fats to fermentation-based ingredients, with Aleph Farms' cultivated beef receiving approval from Israel's Ministry of Health marking a significant regulatory milestone.ForbesDoes Sustainability Have A Scent? Advances In Bioengineering Create Environmentally Responsible MuskBiosynthesis company Conagen, in partnership with Blue California, has successfully produced sustainable plant-based macrocyclic musk using microbial fermentation from plant-based substrates and enzymes, creating both familiar musk compounds and entirely novel fragrance molecules that were previously inaccessible. The companies developed the bio-musk from concept to proof-of-concept in five months, with familiar musk scents potentially reaching store shelves within six months to a year, while novel compounds will require additional time for commercial scale-up and regulatory consideration. The advancement addresses longstanding environmental and health concerns associated with traditional synthetic musks, which are petrochemical-derived, bioaccumulate in organisms and human tissue, and carry a large carbon footprint.GlobeNewswireConagen innovates novel natural-source retinol for cosmetic formulationsConagen developed natural-sourced retinol derivatives via precision fermentation, covalently binding retinol with another cosmetic active. The company plans to commercialize these ingredients in 2024, offering enhanced stability and low irritation. The technology aims to meet rising consumer demand for retinol in beauty products.GlobeNewswireConagen and Sumitomo Chemical jointly develop a new era of renewable carbon materialsConagen and Sumitomo Chemical announced a joint development of p-hydroxystyrene and its polymer, poly p-hydroxystyrene, using biosynthesis, chemosynthesis, and polymerization. The monomer and polymer are 100% renewable carbon, aiming to reduce petroleum-based products. The partnership expects to lower the carbon footprint of traditional chemical synthesis.Pulse 2.0Conagen: Development Of A Debondable Textile Adhesive AnnouncedConagen announced a debondable textile adhesive made from sustainable biomolecules, enabling fabric reworkability and recycling. The adhesive offers strength comparable to traditional adhesives but debonds after heating, with the seam tapes market projected at $128 million in 2020. The technology is compatible with natural and synthetic fibers.GlobeNewswireConagen develops debondable adhesive for textiles and soft materials from natural bioingredientsConagen announced a debondable textile adhesive made from natural biomolecules, enabling fabric reworking and recycling. The adhesive offers strength comparable to traditional adhesives but can be debonded, reducing waste and costs. It is compatible with natural and synthetic fibers and extends to accessories and soft goods.ForbesThis Synthetic Biology Company Is Bringing Royal Fragrances To The MassesConagen, a synthetic biology company, is producing sustainable fragrance ingredients like methyl jasmonate and musk using precision fermentation. The company partners with Sensegen to develop clean, natural scents, aiming to make royal fragrances affordable. More sustainable aromatic ingredients are expected to follow.GlobeNewswireConagen starts first commercial production of sustainable Tyrian purple for textile dyeConagen announced the successful scale-up of its sustainable Tyrian purple dye, produced by fermentation. The company is the first to commercialize this historically rare dye, which reduces pollution and carbon footprints compared to petrochemical alternatives. The dye is intended for textile fabrics and accessories.